Loading…
Elutia Inc. is projected to rise to $0.9895 by 2027, a +14% move from its current price of $0.8669. ELUT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.8431 | $0.867 | $0.8917 | +0.02% |
| Aug 6 | $0.8335 | $0.8672 | $0.9023 | +0.03% |
| Aug 7 | $0.8262 | $0.8673 | $0.9105 | +0.05% |
| Aug 8 | $0.8202 | $0.8675 | $0.9175 | +0.07% |
| Aug 9 | $0.8149 | $0.8676 | $0.9238 | +0.08% |
| Aug 10 | $0.8102 | $0.8678 | $0.9295 | +0.10% |
| Aug 11 | $0.8059 | $0.8679 | $0.9348 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8059 | $0.8679 | $0.9348 | +0.12% |
| Week 2 | $0.7824 | $0.869 | $0.9651 | +0.24% |
| Week 3 | $0.7651 | $0.87 | $0.9893 | +0.36% |
| Week 4 | $0.7509 | $0.871 | $1.01 | +0.48% |
| Week 5 | $0.7388 | $0.8721 | $1.03 | +0.60% |
| Week 6 | $0.728 | $0.8731 | $1.05 | +0.71% |
| Week 7 | $0.7184 | $0.8741 | $1.06 | +0.83% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Elutia Inc. is a commercial-stage healthcare company focused on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The business operates in two segments, Women’s Health and Cardiovascular, and its lead development programs include NXT-41 and NXT-41x, designed as biologic scaffolds combined with local antibiotic delivery.
The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction, and ProxiCor for cardiac tissue repair as an intracardiac patch for repairs such as atrial and ventricular septal defects, suture-line buttressing, and for pericardial closure to reconstruct the pericardium after heart surgery. It also offers Tyke, a thinner pliable matrix for repair of pericardial structures in neonates and infants and as an epicardial patch for damaged or repaired cardiac structures, as well as VasCure for peripheral vasculature repair. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents.
Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland, and it changed its name from Aziyo Biologics, Inc. in September 2023.
Elutia Inc. trades with a current price of $0.88 and a market capitalization of $38.9M, ranking 4654 by market cap. The stock sits in a complex landscape as investors assess near-term dynamics against its longer-term forecast.
A major floor 16.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.1% away) — a key level to hold.
The nearest ceiling, 22.3% above — a clean break opens room to run.
A major ceiling 38.4% above — clearing it would confirm fresh momentum.
Key ELUT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ELUT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.9034 | Sell | $0.8939 | Sell |
| MA 10 | $0.9192 | Sell | $0.9115 | Sell |
| MA 20 | $0.9336 | Sell | $0.9312 | Sell |
| MA 50 | $0.9912 | Sell | $0.9719 | Sell |
| MA 100 | $1.04 | Sell | $1.00 | Sell |
| MA 200 | $0.9397 | Sell | $1.14 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.54 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -224.96 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -10.73 | Sell |
| Bollinger %B (20,2) | -0.17 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.30 | Sell |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 34.37 | Neutral |
| Momentum (10) | -0.09 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 0.88 | Sell |
| ADX (14) | 12.20 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is neutral overall. RSI14 is 40, indicating modest momentum. The stock trades around the key moving averages, with SMA50 at $1.00 and SMA200 at $0.9398.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.614 | $0.8669 | $1.11 | 0% | Neutral | |
| $0.7874 | $0.9895 | $1.32 | +14% | Neutral | |
| $0.9118 | $1.18 | $1.63 | +36% | Bullish | |
| $0.8868 | $1.18 | $1.67 | +36% | Bullish | |
| $0.9424 | $1.28 | $1.86 | +47% | Bullish | |
| $0.9387 | $1.30 | $1.93 | +49% | Bullish | |
| $0.8291 | $1.16 | $1.77 | +34% | Bullish | |
| $0.9181 | $1.31 | $2.03 | +51% | Bullish | |
| $1.04 | $1.51 | $2.38 | +74% | Bullish | |
| $1.13 | $1.67 | $2.66 | +92% | Bullish | |
| $1.19 | $1.88 | $3.19 | +116% | Bullish | |
| $2.10 | $3.74 | $6.98 | +332% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.614 | $0.8669 | $1.00 | +0.00% |
| September 2026 | $0.7097 | $0.8397 | $1.02 | -3.14% |
| October 2026 | $0.7388 | $0.8804 | $1.08 | +4.85% |
| November 2026 | $0.7398 | $0.8866 | $1.10 | +0.71% |
| December 2026 | $0.7342 | $0.8846 | $1.11 | -0.22% |
Click any year to see its month-by-month ELUT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ELUT is projected to trade between $0.614 and $1.11, averaging $0.8669 — a potential gain of 0% from today's $0.8669. A consolidation phase looks the most probable path here.
Elutia Inc.'s 2027 outlook centres on $0.9895, within a $0.7874 to $1.32 range. That is up +14% on the projected 2026 average. That marks a +14% change versus current levels. Price action looks broadly range-bound.
By 2028, ELUT could reach as high as $1.63, with a base case around $1.18 and support toward $0.9118 — roughly +36% from $0.8669. Buyers look set to stay in control over this stretch.
Expect ELUT to range from $0.8868 to $1.67 through 2029. The $1.18 average target implies a +36% move from current prices. That is 0% versus the projected 2028 average. Momentum favours further upside here.
The ELUT price prediction for 2030 points to an average of $1.28 (low $0.9424, high $1.86) — a potential gain of +47% on today's $0.8669. Buyers look set to stay in control over this stretch.
In 2031, ELUT is projected to trade between $0.9387 and $1.93, averaging $1.30 — a potential gain of +49% from today's $0.8669. That is up +2% on the projected 2030 average. Momentum favours further upside here.
Elutia Inc.'s 2032 outlook centres on $1.16, within a $0.8291 to $1.77 range. That is -10% versus the projected 2031 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ELUT could reach as high as $2.03, with a base case around $1.31 and support toward $0.9181 — roughly +51% from $0.8669. Momentum favours further upside here.
Expect ELUT to range from $1.04 to $2.38 through 2034. The $1.51 average target implies a +74% move from current prices. That is up +15% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ELUT price prediction for 2035 points to an average of $1.67 (low $1.13, high $2.66) — a potential gain of +92% on today's $0.8669. Momentum favours further upside here.
In 2040, ELUT is projected to trade between $1.19 and $3.19, averaging $1.88 — a potential gain of +116% from today's $0.8669. That is up +13% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Elutia Inc.'s 2050 outlook centres on $3.74, within a $2.10 to $6.98 range. That is up +99% on the projected 2040 average. That marks a +332% change versus current levels. Momentum favours further upside here.
Investing $1,000 in ELUT today (≈ 1,153.535587 ELUT) could be worth
$4,315.03
+$3,315.03 (+332%) by 2050 · US Dollar
Based on the average projected ELUT price of $3.74 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ELUTwould be worth at today's price.
$1,000 invested in ELUT on Jul 31, 2025 (≈ 492.610844 ELUT) would be worth
$427.04
-$572.96 (-57.3%) today · 0.43× · US Dollar
Based on a ELUT entry price of $2.03 vs. today's $0.8669.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.93 | $932.15 | -6.8% |
| 1 month ago | $0.944 | $918.33 | -8.2% |
| 3 months ago | $1.01 | $858.32 | -14.2% |
| 6 months ago | $1.02 | $849.9 | -15.0% |
| 1 year ago | $2.03 | $427.04 | -57.3% |
| All time (5.0y) ago | $8.05 | $107.72 | -89.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ELUT forecast.
Our base-case forecast reaches $1.70 around 2040.
Implied market cap at $1.70: $75.15M
The multi-year forecast paints a bullish arc after 2026, with year-by-year expectations showing substantial upside potential. In 2026 the avg is $0.88 with a min of $0.614 and a max of $1.13 (ROI 0, sentiment NEUTRAL). From 2027 onward the outlook strengthens: 2027 avg $1.02 (ROI 16.4%), 2028 avg $1.21 (ROI 37.4%), 2029 avg $1.22 (ROI 38.2%), and 2030 avg $1.32 (ROI 50.5%).
The path continues through 2031 avg $1.34 (ROI 52.3%), 2032 avg $1.22 (ROI 39.2%), 2033 avg $1.39 (ROI 58.5%), 2034 avg $1.61 (ROI 82.4%), and 2035 avg $1.76 (ROI 100%). Beyond, 2040 shows avg $2.01 (ROI 128.8%) and 2050 projects avg $4.04 (ROI 358.8%), with a max forecast of $7.42. These figures imply a sustained bullish tilt across the longer horizon, though these are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.32 with a low of $0.985 and a high of $1.92, and an expected ROI of 50.5%. The sentiment is bullish for that year.
The forecast turns increasingly bullish from 2027 onward, with rising averages and positive ROIs in multiple years (e.g., 2027 ROI 16.4%, 2030 ROI 50.5%, 2040 ROI 128.8%, 2050 ROI 358.8%). However, these are estimates, not guarantees, and 2026 shows a neutral stance with an average price of $0.88.
The 2050 forecast presents an average of $4.04 but a maximum of $7.42, implying the potential to exceed $5 in the upper range of outcomes. The longest horizon remains subject to uncertainty.
Current price is $0.88 and the market capitalization is $38.9M.
The 30-day range spans $0.737 to $1.05, with current price at $0.88. Support is at $0.88 and resistance at $1.06. The RSI is 40, SMA50 is $1.00, and SMA200 is $0.9398, with annualized volatility at 50%.
Elutia Inc. Community Discussion
0Share your Elutia Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.